Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

4th generation HIV screening in Massachusetts: a partnership between laboratory and program.

Goodhue T, Kazianis A, Werner BG, Stiles T, Callis BP, Dawn Fukuda H, Cranston K.

J Clin Virol. 2013 Dec;58 Suppl 1:e13-8. doi: 10.1016/j.jcv.2013.08.019.

PMID:
24342473
2.

Performance of the new HIV-1/2 diagnostic algorithm in Florida's public health testing population: a review of the first five months of utilization.

Bennett B, Neumann D, Fordan S, Villaraza R, Crowe S, Gillis L.

J Clin Virol. 2013 Dec;58 Suppl 1:e29-33. doi: 10.1016/j.jcv.2013.08.016. Epub 2013 Aug 27.

PMID:
24342476
3.

Evaluation of the CDC proposed laboratory HIV testing algorithm among men who have sex with men (MSM) from five US metropolitan statistical areas using specimens collected in 2011.

Masciotra S, Smith AJ, Youngpairoj AS, Sprinkle P, Miles I, Sionean C, Paz-Bailey G, Johnson JA, Owen SM.

J Clin Virol. 2013 Dec;58 Suppl 1:e8-e12. doi: 10.1016/j.jcv.2013.09.002. Epub 2013 Sep 12.

PMID:
24342483
4.
5.

Costs and outcomes of laboratory diagnostic algorithms for the detection of HIV.

Hutchinson AB, Ethridge SF, Wesolowski LG, Shrestha RK, Pentella M, Bennett B, Farnham PG, Sullivan T, Patel P, Branson BM.

J Clin Virol. 2013 Dec;58 Suppl 1:e2-7. doi: 10.1016/j.jcv.2013.10.005.

PMID:
24342475
6.

Comparative evaluation of the Bio-Rad Geenius HIV-1/2 Confirmatory Assay and the Bio-Rad Multispot HIV-1/2 Rapid Test as an alternative differentiation assay for CLSI M53 algorithm-I.

Malloch L, Kadivar K, Putz J, Levett PN, Tang J, Hatchette TF, Kadkhoda K, Ng D, Ho J, Kim J.

J Clin Virol. 2013 Dec;58 Suppl 1:e85-91. doi: 10.1016/j.jcv.2013.08.008. Epub 2013 Aug 28.

7.

Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast.

Masciotra S, Luo W, Youngpairoj AS, Kennedy MS, Wells S, Ambrose K, Sprinkle P, Owen SM.

J Clin Virol. 2013 Dec;58 Suppl 1:e54-8. doi: 10.1016/j.jcv.2013.07.002. Epub 2013 Aug 2.

PMID:
23911678
8.

Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections.

Masciotra S, McDougal JS, Feldman J, Sprinkle P, Wesolowski L, Owen SM.

J Clin Virol. 2011 Dec;52 Suppl 1:S17-22. doi: 10.1016/j.jcv.2011.09.011. Epub 2011 Oct 5.

PMID:
21981983
9.

Evaluation of the Bio-Rad Multispot HIV-1/HIV-2 Rapid Test as an alternative to Western blot for confirmation of HIV infection.

Cárdenas AM, Baughan E, Hodinka RL.

J Clin Virol. 2013 Dec;58 Suppl 1:e97-e103. doi: 10.1016/j.jcv.2013.08.021. Epub 2013 Aug 30.

PMID:
24113294
10.

Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors.

Wesolowski LG, Delaney KP, Hart C, Dawson C, Owen SM, Candal D, Meyer WA 3rd, Ethridge SF, Branson BM.

J Clin Virol. 2011 Dec;52 Suppl 1:S45-9. doi: 10.1016/j.jcv.2011.09.026. Epub 2011 Oct 12.

PMID:
21995934
11.

Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithm.

Nasrullah M, Wesolowski LG, Meyer WA 3rd, Owen SM, Masciotra S, Vorwald C, Becker WJ, Branson BM.

AIDS. 2013 Mar 13;27(5):731-7. doi: 10.1097/QAD.0b013e32835bc535.

12.

Detection of acute HIV-1 infections utilizing NAAT technology in Dallas, Texas.

Emerson B, Plough K.

J Clin Virol. 2013 Dec;58 Suppl 1:e48-53. doi: 10.1016/j.jcv.2013.08.005. Epub 2013 Aug 13.

PMID:
23999031
13.

Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection.

Ramos EM, Harb S, Dragavon J, Swenson P, Stekler JD, Coombs RW.

J Clin Virol. 2013 Dec;58 Suppl 1:e38-43. doi: 10.1016/j.jcv.2013.08.014. Epub 2013 Aug 26.

14.

Comparison of Multispot EIA with Western blot for confirmatory serodiagnosis of HIV.

Torian LV, Forgione LA, Punsalang AE, Pirillo RE, Oleszko WR.

J Clin Virol. 2011 Dec;52 Suppl 1:S41-4. doi: 10.1016/j.jcv.2011.09.017. Epub 2011 Oct 12.

PMID:
21995935
15.

Nucleic acid testing by public health referral laboratories for public health laboratories using the U.S. HIV diagnostic testing algorithm.

Wesolowski LG, Wroblewski K, Bennett SB, Parker MM, Hagan C, Ethridge SF, Rhodes J, Sullivan TJ, Ignacio-Hernando I, Werner BG, Owen SM.

J Clin Virol. 2015 Apr;65:6-10. doi: 10.1016/j.jcv.2015.01.017. Epub 2015 Jan 24.

16.

Screening for acute human immunodeficiency virus infection in Baltimore public testing sites.

Temkin E, Marsiglia VC, Hague C, Erbelding E.

Sex Transm Dis. 2011 May;38(5):374-7. doi: 10.1097/OLQ.0b013e31820279bd.

PMID:
21183865
18.

Use of the Abbott Architect HIV antigen/antibody assay in a low incidence population.

Dubravac T, Gahan TF, Pentella MA.

J Clin Virol. 2013 Dec;58 Suppl 1:e76-8. doi: 10.1016/j.jcv.2013.10.020.

PMID:
24342481
19.

Evaluation of supplemental testing with the Multispot HIV-1/HIV-2 Rapid Test and APTIMA HIV-1 RNA Qualitative Assay to resolve specimens with indeterminate or negative HIV-1 Western blots.

Linley L, Ethridge SF, Oraka E, Owen SM, Wesolowski LG, Wroblewski K, Landgraf KM, Parker MM, Brinson M, Branson BM.

J Clin Virol. 2013 Dec;58 Suppl 1:e108-12. doi: 10.1016/j.jcv.2013.09.021.

PMID:
24342469
20.

Use of rapid HIV assays as supplemental tests in specimens with repeatedly reactive screening immunoassay results not confirmed by HIV-1 Western blot.

Wesolowski LG, Delaney KP, Meyer WA 3rd, Blatt AJ, Bennett B, Chavez P, Granade TC, Owen M.

J Clin Virol. 2013 Sep;58(1):240-4. doi: 10.1016/j.jcv.2013.06.019. Epub 2013 Jul 6.

Supplemental Content

Support Center